FI885031A0 - Vaextregulator av blodplaettetyp. - Google Patents
Vaextregulator av blodplaettetyp.Info
- Publication number
- FI885031A0 FI885031A0 FI885031A FI885031A FI885031A0 FI 885031 A0 FI885031 A0 FI 885031A0 FI 885031 A FI885031 A FI 885031A FI 885031 A FI885031 A FI 885031A FI 885031 A0 FI885031 A0 FI 885031A0
- Authority
- FI
- Finland
- Prior art keywords
- vaextregulator
- blodplaettetyp
- polypeptide
- src
- induce
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/495—Transforming growth factor [TGF]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/521—Chemokines
- C07K14/522—Alpha-chemokines, e.g. NAP-2, ENA-78, GRO-alpha/MGSA/NAP-3, GRO-beta/MIP-2alpha, GRO-gamma/MIP-2beta, IP-10, GCP-2, MIG, PBSF, PF-4, KC
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
- C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
- C12N15/73—Expression systems using phage (lambda) regulatory sequences
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/50—Fusion polypeptide containing protease site
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Plant Pathology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2060987A | 1987-03-02 | 1987-03-02 | |
US2060987 | 1987-03-02 | ||
US11513987A | 1987-10-30 | 1987-10-30 | |
US11513987 | 1987-10-30 | ||
PCT/US1988/000634 WO1988006628A1 (en) | 1987-03-02 | 1988-02-26 | Platelet related growth regulator |
US8800634 | 1988-02-26 |
Publications (3)
Publication Number | Publication Date |
---|---|
FI885031A FI885031A (fi) | 1988-11-01 |
FI885031A0 true FI885031A0 (fi) | 1988-11-01 |
FI100336B FI100336B (fi) | 1997-11-14 |
Family
ID=26693642
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI885031A FI100336B (fi) | 1987-03-02 | 1988-11-01 | Ilmentämiskasetti, menetelmä ja isäntäsolu fuusioproteiinin valmistami seksi |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0281363B1 (fi) |
JP (1) | JPH01503513A (fi) |
KR (1) | KR890700672A (fi) |
AT (1) | ATE123061T1 (fi) |
AU (1) | AU623589B2 (fi) |
DE (1) | DE3853842T2 (fi) |
ES (1) | ES2074049T3 (fi) |
FI (1) | FI100336B (fi) |
GR (1) | GR3017041T3 (fi) |
IE (1) | IE69678B1 (fi) |
IL (1) | IL85613A (fi) |
NZ (1) | NZ223696A (fi) |
PT (1) | PT86885B (fi) |
WO (1) | WO1988006628A1 (fi) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4844895A (en) * | 1985-11-01 | 1989-07-04 | New York University | Composition containing a peptide fragment of platelet factor four and method for restoring suppressed immune responses |
US5026639A (en) * | 1988-01-14 | 1991-06-25 | Nippon Mining Company, Limited | Method to improve mRNA translation and use thereof for production of platelet factor-4 |
GB2214508A (en) * | 1988-01-27 | 1989-09-06 | Bayer Ag | Plasmid vector for the efficient expression of foreign genes fused with newly conceived transcriptional and translational signal sequences. |
US5800820A (en) * | 1989-01-10 | 1998-09-01 | Repligen Corporation | Methods and compositions for treatment of angiogenic diseases |
US5086164A (en) * | 1989-01-10 | 1992-02-04 | Repligen Corporation | Novel methods and compositions for treatment of angiogenic diseases |
US5187075A (en) * | 1989-01-26 | 1993-02-16 | Sri International | Cloning and expression of a variant gene of platelet factor 4 and compositions thereof to modulate immune responses |
US5112946A (en) * | 1989-07-06 | 1992-05-12 | Repligen Corporation | Modified pf4 compositions and methods of use |
CA2113206A1 (en) * | 1991-07-15 | 1993-02-04 | Theodore E. Maione | Modified pf4 compositions and methods of use |
AU3592593A (en) * | 1992-01-16 | 1993-08-03 | Repligen Corporation | Novel methods and compositions for treatment of angiogenic diseases |
WO1995012414A1 (en) * | 1993-11-05 | 1995-05-11 | Repligen Corporation | Novel modified pf4 compositions and methods of use |
IL113561A0 (en) * | 1994-05-09 | 1995-08-31 | Lilly Co Eli | Expression of recombinant mpf-4, cpf-4, pf-4 and precursor compounds |
US5985543A (en) * | 1996-10-11 | 1999-11-16 | The Trustees Of The University Of Pennsylvania | Compositions and methods for detection of antibody binding to cells |
US7067117B1 (en) | 1997-09-11 | 2006-06-27 | Cambridge University Technical Services, Ltd. | Compounds and methods to inhibit or augment an inflammatory response |
US6989435B2 (en) | 1997-09-11 | 2006-01-24 | Cambridge University Technical Services Ltd. | Compounds and methods to inhibit or augment an inflammatory response |
US7238711B1 (en) | 1999-03-17 | 2007-07-03 | Cambridge University Technical Services Ltd. | Compounds and methods to inhibit or augment an inflammatory response |
WO2007053952A1 (en) * | 2005-11-10 | 2007-05-18 | Chemokine Therapeutics Corporation | Platelet factor-4 (pf-4) analogs and their use |
NZ527590A (en) | 2001-03-09 | 2005-12-23 | Genentech Inc | Process for production of polypeptides |
US8609621B2 (en) | 2010-11-15 | 2013-12-17 | E I Du Pont De Nemours And Company | Acid-cleavable linkers exhibiting altered rates of acid hydrolysis |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4565785A (en) * | 1978-06-08 | 1986-01-21 | The President And Fellows Of Harvard College | Recombinant DNA molecule |
IL60184A (en) * | 1979-05-31 | 1984-05-31 | Schering Ag | Process for the specific cleavage of protein sequences from proteins |
US4530901A (en) * | 1980-01-08 | 1985-07-23 | Biogen N.V. | Recombinant DNA molecules and their use in producing human interferon-like polypeptides |
US4582800A (en) * | 1982-07-12 | 1986-04-15 | Hoffmann-La Roche Inc. | Novel vectors and method for controlling interferon expression |
SE8300693L (sv) * | 1983-02-09 | 1984-08-10 | Sven Lofdahl | Sett att framstella och isolera proteiner och polypeptider samt en hybridvektor for detta |
EP0133123A1 (en) * | 1983-07-25 | 1985-02-13 | Mgi Pharma, Inc. | Immunogens of papilloma viruses |
US4645828A (en) * | 1984-03-23 | 1987-02-24 | Oncogen | Platelet related growth regulator |
WO1986001828A1 (en) * | 1984-09-18 | 1986-03-27 | Sagami Chemical Research Center | Cyclic double-stranded dna, process for its preparation, microorganism containing said cyclic double-stranded dna, and process for preparing protein containing antigen determinant site of poliovirus capside protein vp1 using the same |
JPH0816063B2 (ja) * | 1985-03-15 | 1996-02-21 | オンコゲン | 腫瘍細胞増殖阻害剤 |
EP0196864A3 (en) * | 1985-03-25 | 1988-03-23 | Cetus Corporation | Alkaline phosphatase-mediated processing and secretion of recombinant proteins, dna sequences for use therein and cells transformed using such sequences |
JPS61280292A (ja) * | 1985-06-04 | 1986-12-10 | Wakunaga Pharmaceut Co Ltd | 菌体外分泌による蛋白質の製造法 |
-
1988
- 1988-02-26 AU AU14924/88A patent/AU623589B2/en not_active Ceased
- 1988-02-26 WO PCT/US1988/000634 patent/WO1988006628A1/en active IP Right Grant
- 1988-02-26 JP JP63502722A patent/JPH01503513A/ja active Pending
- 1988-03-01 DE DE3853842T patent/DE3853842T2/de not_active Expired - Fee Related
- 1988-03-01 NZ NZ223696A patent/NZ223696A/en unknown
- 1988-03-01 ES ES88301774T patent/ES2074049T3/es not_active Expired - Lifetime
- 1988-03-01 AT AT88301774T patent/ATE123061T1/de not_active IP Right Cessation
- 1988-03-01 EP EP88301774A patent/EP0281363B1/en not_active Expired - Lifetime
- 1988-03-02 PT PT86885A patent/PT86885B/pt not_active IP Right Cessation
- 1988-03-02 IE IE59188A patent/IE69678B1/en not_active IP Right Cessation
- 1988-03-02 IL IL8561388A patent/IL85613A/en not_active IP Right Cessation
- 1988-11-01 FI FI885031A patent/FI100336B/fi not_active IP Right Cessation
- 1988-11-02 KR KR1019880701398A patent/KR890700672A/ko not_active Application Discontinuation
-
1995
- 1995-08-08 GR GR950402158T patent/GR3017041T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
NZ223696A (en) | 1991-06-25 |
KR890700672A (ko) | 1989-04-26 |
IE69678B1 (en) | 1996-10-02 |
PT86885A (pt) | 1989-03-30 |
EP0281363B1 (en) | 1995-05-24 |
IE880591L (en) | 1988-09-02 |
GR3017041T3 (en) | 1995-11-30 |
EP0281363A3 (en) | 1988-11-17 |
EP0281363A2 (en) | 1988-09-07 |
IL85613A (en) | 1994-10-07 |
WO1988006628A1 (en) | 1988-09-07 |
AU1492488A (en) | 1988-09-26 |
ES2074049T3 (es) | 1995-09-01 |
FI885031A (fi) | 1988-11-01 |
AU623589B2 (en) | 1992-05-21 |
FI100336B (fi) | 1997-11-14 |
JPH01503513A (ja) | 1989-11-30 |
IL85613A0 (en) | 1988-08-31 |
ATE123061T1 (de) | 1995-06-15 |
PT86885B (pt) | 1995-08-09 |
DE3853842T2 (de) | 1995-12-07 |
DE3853842D1 (de) | 1995-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK540685A (da) | Blodpladepeptidbeslaegtet vaekstregulator | |
FI885031A (fi) | Vaextregulator av blodplaettetyp. | |
DE3789320D1 (de) | Verabreichungsinstrument zum Einführen von festen Medikamenten. | |
ZA896468B (en) | Lyophilization of red blood cells | |
DE3888642D1 (de) | Rollflasche zur Züchtung von Zellengewebekulturen. | |
NO820090L (no) | Fremgangsmaate for fremstilling og behandling av renninderivater | |
PH22461A (en) | Preparation of functional human urokinase protein | |
DE3674906D1 (de) | Selbstklemmende medizinische prothese und ihre herstellung. | |
NO164991C (no) | Fremgangsmaate for fremstilling av blodkoaguleringshemmende proteiner. | |
CS715886A1 (en) | Synthetic medium for the cultivation of myelomic cells | |
NO880268D0 (no) | Fremgangsmaate for fremstilling av anti-koagulerende peptider. | |
DE3268915D1 (en) | Angiotropins of leukocytes and inflamed tissue: a new class of natural chemotropic protein mitogens for specific induction of directional growth of blood vessels, neovascularization of tissues and morphogenesis of blood vessel patterns, process for their biotechnical preparation and pharmaceutical compositions | |
NO884995L (no) | 2',3'-dideoksy-2'-fluornukleosider, fremstilling derav samt preparater inneholdende disse. | |
DK87190A (da) | Fremgangsmaade til at regulere plantevaekst under anvendelse af svovlholdige organiske syrer | |
DE3781483D1 (de) | Pharmazeutische zusammensetzung zum schutz von gehirnzellen. | |
IT1223416B (it) | Procedimento per la realizzazione di calzature del tipo ciabatta, nonche' ciabatta cosi' realizzata | |
IT8767940A0 (it) | Procedimento microbiologico per lapreparazione di 9 alfa -idrossi4-androstene-3,17 dione | |
EP0136093A3 (en) | Anti-cancer factors | |
AU6592890A (en) | Treatment of multi-drug resistant tumors with quinolyloxazole-2-ones | |
DE68911305D1 (de) | Das lungenwachstum stimulierende und hemmende faktoren für krebstumorzellen. | |
EP0331743A4 (en) | PROTEIN DERIVED FROM A LIVING BODY. | |
NO158020C (no) | Fremgangsmaate for fremstilling av optisk rent s-3-morfolino-4-(3'-tertbutylamino-2'-hydroxypropoxy)-1,2,5-thiadiazol | |
TR22570A (tr) | Derinin seri olarak tabaklan masina mahsus usul | |
FI893001A0 (fi) | Foerfarande foer framstaellning av nya, terapeutiskt anvaendbara 1,2-bensisoxazol-3-yl- och 1,2-bensisotiazol -3-ylderivat. | |
CS715986A1 (en) | Process for the cultivation of myelomic cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM | Patent lapsed |
Owner name: ONCOGEN, A LIMITED PARTNERSHIP |